Precision Biosciences Inc
DTIL
Market Cap$67.23M
Close$
$16.72
59.5% upside
Current Fair Value
59.5% upsideUndervalued by 59.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $67.23 Million |
|---|---|
| Enterprise Value | $-18,184,157.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-15.96 |
| Beta | 0.0 |
| Outstanding Shares | 6,916,239 |
| Avg 30 Day Volume | 112,402 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.1 |
|---|---|
| PEG | 2.56 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 5.24 |
| Enterprise Value to Revenue | -0.37 |
| Enterprise Value to EBIT | 0.38 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.72 |
| Debt to Equity | 1.66 |
Revenue Sources
No data
ESG Score
No data
About Precision Biosciences Inc
CEO: Matthew Kane